Around the Precinct – 19 August 2021

As many of our researchers focus on solving the critical health challenges of our time – COVID-19 and heart disease among them – some members of the Alfred Research Alliance are looking beyond the microscope to the broader healthcare settings we operate in.

A new study from Monash University examines the current status for women in leadership positions and the strategies that can drive change for generations to come. Others are investigating the inequalities of the Australian healthcare system, and how this affects access to health services for the most vulnerable cohorts of our population.

Also this week, in an endorsement of the Alfred precinct’s world-leading research capabilities, one of our members, 360biolabs, has been purchased by US contract research laboratory BioAgilytix. The sale marks a transformational day for fellow Alliance member and majority owner of 360biolabs, Burnet Institute.

Monash University women in leadership

A new study from Monash University has identified strategies that can help advance women in leadership.

Monash University – Central Clinical School

The acid test: The case for accurate and quick mobile point-of-care COVID testing
Monash researchers make the case for investing in development and deployment of decentralised diagnostic devices, most importantly a highly-mobile and swift point-of-care (POC) COVID-19 nucleic acid test.
Read more

Monash University – School of Public Health and Preventive Medicine

Decades of research on advancing women in leadership shows that effective strategies can drive change
Monash University research has identified a ‘toolbox’ of effective interventions that can be implemented to advance women in leadership, with specific lessons for healthcare.
Read more

How equitable is Australia’s maternal healthcare?
Disparities in health service use exist in many sectors of Australia’s health system, and they particularly affect the most vulnerable people in the population, who are typically those with the greatest healthcare needs.
Read more

Climate change: Collective action a counterpoint to Australian government inaction
My colleagues and I just published data showing that Australians are almost three times more worried about climate change than COVID, with many showing signs of PTSD from past or future climate-related, catastrophic events.
Read more

Baker Heart and Diabetes Institute

How hidden ageing could lead our heart to malfunction
Australian cardiovascular experts have revealed the number of people with heart valve problems that could lead the heart to malfunction is rising rapidly, particularly as the population ages.
Read more

Burnet Institute

Vale Professor Evelyn Lavu
The Burnet Institute community has been deeply saddened with the tragic news of the sudden death in Papua New Guinea of our colleague and friend, Professor Evelyn Lavu.
Read more

Podcast Ep. 2: Are vaccines the silver bullet?
In this episode of How Science Matters, you’ll meet Burnet Institute’s Professor Heidi Drummer, Program Director of Disease Elimination, who thinks no-one will be untouched by COVID-19 in 20 years’ time, and why the need for a coronavirus vaccine is up there with measles or smallpox.
Read more

From ground zero to zero tolerance – how China learnt from its COVID response to quickly stamp out its latest outbreak
Professor Mike Toole AM writes for The Conversation about how China went from pandemic epicentre with a dark history of silencing those who spoke out about the risks of the virus, to rapidly containing the virus in its latest outbreak.
Read more

Transformational day for Burnet with the sale of 360biolabs
The Burnet Institute majority owned company 360biolabs has signed an agreement to be purchased by BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory headquartered in the USA.
Read more

Burnet Statement on Afghanistan
Burnet Institute expresses grave concern about the health and safety of the Afghan people as the Taliban occupies the capital, Kabul.
Read more

ACMI to facilitate access to modelling
Burnet Institute is a collaborator in an exciting new initiative, the Australian COVID-19 Modelling Initiative (ACMI), to facilitate access to the latest COVID-19 modelling for the public and policy makers.
Read more

Podcast Ep. 1: A year like no other, the pandemic continues
If the narrative of the COVID-19 pandemic was told as a fairy tale, it would resemble the literary classic, Goldilocks and the Three Bears. That’s according to Burnet Institute CEO, Professor Brendan Crabb AC, the co-host of the new podcast series, How Science Matters.
Read more


BioAgilytix to purchase Australia based 360biolabs
Highly complementary transaction will strengthen company’s ability to support bioanalytical services across all stages, development capabilities and geographies.
Read more